| | | | | |
ANIK Anika Therapeutics Inc | $21.6400 | +0.33% | $294.82M | $74.55K | |
BACC Blue Acquisition Corp. Class A Ordinary Shares | $10.4600 | -0.19% | $294.73M | $397.00 | |
GPAC General Purpose Acquisition Corp. Class A Ordinary Shares | $10.0400 | +0.00% | $294.68M | $310.00 | |
BPRN Princeton Bancorp, Inc. Common Stock (PA) | $43.0000 | -0.37% | $294.53M | $1.03K | |
| $45.1150 | -0.08% | $294.35M | $12.73K | |
ACGC ACP Holdings Acquisition Corp. Class A Ordinary Shares | $10.0190 | +0.19% | $294.35M | $100.01K | |
HCAC Hall Chadwick Acquisition Corp Class A Ordinary Shares | $10.0700 | -0.10% | $294.33M | $187.00 | |
SLN Silence Therapeutics Plc American Depository Share | $14.0800 | -0.14% | $294.27M | $2.31K | |
MTNE CH4 Natural Solutions Corporation | $9.8750 | +0.04% | $293.88M | $6.000 | |
RXST RxSight, Inc. Common Stock | $6.3700 | +0.00% | $293.64M | $703.00 | |
NHIC NewHold Investment Corp III Class A Ordinary shares | $10.6400 | -0.09% | $293.52M | $245.00 | |
IRHO Iron Horse Acquisitions II Corp. Common Stock | $10.0050 | +0.00% | $293.49M | $86.47K | |
CNXU Conexeu Sciences Inc. Common Stock | $10.0000 | +0.10% | $293.27M | $1.80K | |
| $10.0160 | +0.26% | $292.98M | $1.66K | |
JCE Nuveen Core Equity Alpha Fund | $17.0800 | +0.00% | $292.78M | $22.90K | |
